1. Bokeria, L.A., Filatov, A.G. Kovalev, S.A., and Kovalev, A.S., Treatment of atrial fibrillation: data from randomized trials, Vestn. Eksp. Klin. Khir., 2012, vol. 5, no. 2, p. 448.
2. Borisova, E.V., Plekhanov, I.G., and Popov, S.V., Quality of life of patients after the creation of a complete atrioventricular block and implantation of a frequency-adaptive pacemaker, Sib. Med. Zh., 2013, vol. 28, no. 2, p. 74.
3. Proietti, M., Farcomeni, A., Romiti, G.F., et al., Association between clinical risk scores and mortality in atrial fibrillation: Systematic review and network meta-regression of 669.000 patients, Eur. J. Prevent. Cardiol., 2020, vol. 27, no. 6, p. 633.
4. Frommeyer, G., Eckardt, L., and Milberg, P., Calcium handling and ventricular tachyarrhythmias, Wien. Med. Wochenschr., 2012, vol. 162, nos. 13–14, p. 283.
5. Schlotthauer, K. and Bers, D.M., Sarcoplasmic reticulum Ca2+ release causes myocyte depolarization. Underlying mechanism and threshold for triggered action potentials, Circ. Res., 2000, vol. 87, no. 9, p. 774.